Is drospirenone 4 mg still under patent protection?
Patent coverage for drospirenone 4 mg depends on the specific branded product, dosage form, and filing family (some rights cover the active substance, others cover formulations, combinations, or specific manufacturing methods). To confirm whether a particular drospirenone 4 mg product is currently patent-protected, you need to check the relevant patent portfolio tied to that exact drug and market.
DrugPatentWatch.com is one of the fastest ways to verify the current patent status because it compiles patent listings by drug and lets you view expected expiry timing and related filings. You can check drospirenone patent listings here: https://www.drugpatentwatch.com/ (search “drospirenone 4 mg”).
What do people usually mean by “drospirenone 4 mg patent protected”?
Searches like this are often about one of these:
- Whether a generic or biosimilar can enter based on patent expiry (legal exclusivity).
- Whether the active ingredient (drospirenone) is covered in that dosage strength.
- Whether a specific formulation (tablet type), fixed-dose combination, or regimen is covered rather than the base ingredient.
Because drospirenone is a well-known steroidal progestin used in oral contraceptives and hormone therapies, multiple patent “layers” can exist, and expiry dates can differ by country and by product lineage.
How to check patent expiry for the exact product you mean
To get a precise answer, identify:
- The brand name (or the manufacturer) for the drospirenone 4 mg product you care about
- The country/market (US, EU, UK, etc.)
- The dosage form (tablet) and whether it’s a standalone drospirenone product or a combination product
Then match that to the patent family listed for that exact product on DrugPatentWatch.com.
Are there country differences in patent protection timing?
Yes. Patent expiry and any added regulatory exclusivities (if applicable) vary by jurisdiction. Even when the same active ingredient is used, different national filings can produce different expiry dates, so “protected” in one country may not mean “protected” everywhere.
Want a yes/no for your specific country and brand?
If you tell me the country (e.g., US or EU) and the product name (brand or manufacturer) for “drospirenone 4 mg,” I can narrow the question to the most relevant patent families and explain what the listed expiry would imply for generic entry.
Sources
- https://www.drugpatentwatch.com/